OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TREM2 in Neurodegenerative Diseases
Taylor R. Jay, Victoria E. von Saucken, Gary E. Landreth
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 333

Showing 1-25 of 333 citing articles:

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng, Paul Edison
Nature Reviews Neurology (2020) Vol. 17, Iss. 3, pp. 157-172
Closed Access | Times Cited: 2069

Microglia in Alzheimer’s disease
David V. Hansen, Jesse E. Hanson, Morgan Sheng
The Journal of Cell Biology (2017) Vol. 217, Iss. 2, pp. 459-472
Open Access | Times Cited: 1574

Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
Stephen S. Dominy, Casey Lynch, Florian Ermini, et al.
Science Advances (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 1434

Microglia in neurodegeneration
Suzanne E. Hickman, Saef Izzy, Pritha Sen, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1359-1369
Open Access | Times Cited: 1380

DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong, Lei Liu, Wei Jiang, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 2, pp. 95-112
Closed Access | Times Cited: 1288

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki, Na Zhao, Thomas R. Caulfield, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 501-518
Open Access | Times Cited: 1045

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao, Xilin Wu, Xiaoguang Li, et al.
Neuron (2018) Vol. 97, Iss. 5, pp. 1023-1031.e7
Open Access | Times Cited: 568

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 555

Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 445

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 426

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Darshpreet Kaur, Vivek Sharma, Rahul Deshmukh
Inflammopharmacology (2019) Vol. 27, Iss. 4, pp. 663-677
Closed Access | Times Cited: 372

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
Li Zhong, Ying Xu, Rengong Zhuo, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 290

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Junling Yang, Leslie Wise, Ken‐ichiro Fukuchi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
Marc Suárez‐Calvet, Estrella Morenas‐Rodríguez, Gernot Kleinberger, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 268

Microglia: Agents of the CNS Pro-Inflammatory Response
José A. Rodríguez‐Gómez, Edel Kavanagh, Pinelopi Engskog-Vlachos, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1717-1717
Open Access | Times Cited: 264

TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice
Shengpan Chen, Jianhua Peng, Prativa Sherchan, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 247

Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases
Hiroyuki Konishi, Hiroshi Kiyama
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 245

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Lin Jia, Juan C. Piña‐Crespo, Yonghe Li
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 226

The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders
Susana Carmona, Kathleen R. Zahs, Elizabeth Wu, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 8, pp. 721-730
Open Access | Times Cited: 210

Neuroinflammation in frontotemporal dementia
Fiona Bright, Eryn L. Werry, Carol Dobson‐Stone, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 540-555
Closed Access | Times Cited: 209

Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
Amanda McQuade, Mathew Blurton‐Jones
Journal of Molecular Biology (2019) Vol. 431, Iss. 9, pp. 1805-1817
Open Access | Times Cited: 198

The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
Paul J. Cheng-Hathaway, Erin G. Reed-Geaghan, Taylor R. Jay, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 179

Lipid and Lipoprotein Metabolism in Microglia
Bailey A. Loving, Kimberley D. Bruce
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 176

Alzheimer’s Disease, Oligomers, and Inflammation
Gianluigi Forloni, Claudia Balducci
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 3, pp. 1261-1276
Open Access | Times Cited: 165

Page 1 - Next Page

Scroll to top